Certain Maternal Antibodies in Relation to Doppler in Hypertension With Pregnancy
- Conditions
- Pre-Eclampsia
- Interventions
- Diagnostic Test: DopplerDiagnostic Test: serum antibodies
- Registration Number
- NCT03214393
- Lead Sponsor
- Cairo University
- Brief Summary
Relation of certain maternal serum antibodies to Doppler changes will be studied in cases suffering from hypertension with pregnancy.
- Detailed Description
Assessment will be done for maternal serum anti-beta 2 glycoprotein 1 antibodies and anticardiolipin antibodies in cases of preeclampsia after 32 weeks of pregnancy. In addition, fetal Doppler changes will be assessed.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- Pregnant women 32 weeks or more gestational age
- Pre-eclampsia
- Singleton pregnancy
Read More
Exclusion Criteria
- Intrauterine fetal death
- Fetus with apparent congenital anomalies
- Pregnant females with other medical disorders
- History of essential hypertension.
- History of antepartum hemorrhage.
- History of rupture of membranes.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pre-Eclampsia serum antibodies pregnant women with Pre-Eclampsia will be assessed by serum antibodies and Doppler Pre-Eclampsia Doppler pregnant women with Pre-Eclampsia will be assessed by serum antibodies and Doppler
- Primary Outcome Measures
Name Time Method percentage of cases that develop severe pre-eclampsia It will be calculated after 1 year from the start of the study percentage of cases that develop severe pre-eclampsia will be assessed by an investigator
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Obstetrics and Gynecology
🇪🇬Cairo, Greater Cairo, Egypt